المؤلفون: Woff, Erwin, Hendlisz, Alain, Garcia, Camilo, Deleporte, Amélie, Delaunoit, Thierry, Marechal, Raphaël, Holbrechts, S., Van Den Eynde, Marc, Demolin, Gauthier, Vierasu, Irina, Lhommel, Renaud, Gauthier, Namur, Guiot, Thomas, Ameye, Lieveke, Flamen, Patrick

المصدر: European journal of nuclear medicine and molecular imaging, 43 (10

مصطلحات موضوعية: Imagerie médicale, radiologie, tomographie, Adult, Aged, Antineoplastic Combined Chemotherapy Protocols -- administration & dosage, Capecitabine -- administration & dosage, Colorectal Neoplasms -- diagnostic imaging -- drug therapy -- secondary, Drug Monitoring -- methods, Female, Fluorodeoxyglucose F18 -- pharmacokinetics, Humans, Male, Middle Aged, Molecular Targeted Therapy -- methods, Niacinamide -- administration & dosage -- analogs & derivatives, Phenylurea Compounds -- administration & dosage, Positron Emission Tomography Computed Tomography -- methods, Radiopharmaceuticals -- pharmacokinetics, Reproducibility of Results, Sensitivity and Specificity, Sorafenib, Treatment Outcome, Early metabolic response assessment, FDG PET-CT, Metastatic colorectal cancer, Targeted therapy, Tumoral heterogeneity

وصف الملف: 1 full-text file(s): application/pdf

العلاقة: uri/info:doi/10.1007/s00259-016-3365-x; uri/info:pii/10.1007/s00259-016-3365-x; uri/info:pmid/27072811; uri/info:scp/84963685661; uri/info:pmcid/PMC4969337; https://dipot.ulb.ac.be/dspace/bitstream/2013/282990/3/doi_266617.pdfTest; http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/282990Test

الإتاحة: http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/282990Test

المؤلفون: Hottinger, A F, Ben Aissa, Assma, Espeli, Vittoria, Squiban, D, Dunkel, Nathalie, Vargas Gomez, Maria Isabel, Hundsberger, T, Mach, Nicolas, Schaller, Karl Lothard, Weber, D C, Bodmer, A, Dietrich, Pierre-Yves

المصدر: ISSN: 0007-0920 ; British journal of cancer, vol. 110, no. 11 (2014) p. 2655-2661.

مصطلحات موضوعية: info:eu-repo/classification/ddc/616.8, info:eu-repo/classification/ddc/616.0757, info:eu-repo/classification/ddc/616, Adult, Aged, Antineoplastic Combined Chemotherapy Protocols/pharmacokinetics/therapeutic use/toxicity, Brain Neoplasms/mortality/therapy, Chemoradiotherapy, Dacarbazine/administration & dosage/analogs & derivatives, Disease-Free Survival, Female, Glioblastoma/mortality/therapy, Humans, Male, Maximum Tolerated Dose, Middle Aged, Niacinamide/administration & dosage/analogs & derivatives, Phenylurea Compounds/administration & dosage, Treatment Outcome

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/24786603; https://archive-ouverte.unige.ch/unige:90881Test; unige:90881

الإتاحة: https://doi.org/10.1038/bjc.2014.209Test
https://archive-ouverte.unige.ch/unige:90881Test

المؤلفون: Beuselinck, B, Wolter, P, Karadimou, A, Elaidi, R, Dumez, Herlinde, Rogiers, Annick, Van Cann, T, Willems, L, Body, Jean-Jacques, Berkers, J, Van Poppel, H, Lerut, E, Debruyne, P, Paridaens, R, Schöffski, P

المصدر: British Journal of Cancer, 107 (10

مصطلحات موضوعية: Sciences bio-médicales et agricoles, Antineoplastic Combined Chemotherapy Protocols -- adverse effects -- therapeutic use, Bone Density Conservation Agents -- administration & dosage -- adverse effects, Bone Neoplasms -- drug therapy -- pathology -- secondary, Carcinoma, Renal Cell -- drug therapy -- pathology -- secondary, Diphosphonates -- administration & dosage -- adverse effects, Disease-Free Survival, Female, Humans, Indoles -- administration & dosage, Kidney Neoplasms -- drug therapy -- pathology, Male, Middle Aged, Neoplasm Metastasis, Niacinamide -- administration & dosage -- analogs & derivatives, Osteonecrosis -- chemically induced, Phenylurea Compounds -- administration & dosage, Prognosis, Protein Kinase Inhibitors -- administration & dosage, Protein-Tyrosine Kinases -- antagonists & inhibitors, Pyrroles -- administration & dosage, Retrospective Studies, Treatment Outcome, Bisphosphonates, Bone metastases, Osteonecrosis of the jaw, Outcome, Renal cell carcinoma, Targeted therapy

وصف الملف: 1 full-text file(s): application/pdf

العلاقة: uri/info:doi/10.1038/bjc.2012.385; uri/info:pii/bjc2012385; uri/info:pmid/23132391; uri/info:scp/84869225968; https://dipot.ulb.ac.be/dspace/bitstream/2013/143043/3/doi_126664.pdfTest; http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/143043Test

الإتاحة: http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/143043Test

المؤلفون: Pierre Laurent-Puig, Sylvain Poujol, Françoise Desseigne, S. Thezenas, Thibault Mazard, Evelyne Crapez, Emmanuelle Samalin, E. Francois, Antoine Adenis, T. Conroy, J.F. Seitz, Julien Taieb, M.P. Galais, Jaafar Bennouna, F. Boissière, Marc Ychou, Eric Assenat, O. Bouche, Frédéric Bibeau

المساهمون: CRLCC Val d'Aurelle - Paul Lamarque, Hôpital universitaire Robert Debré [Reims], Centre de Lutte contre le Cancer Antoine Lacassagne [Nice] (UNICANCER/CAL), UNICANCER-Université Côte d'Azur (UCA), Centre Régional de Lutte contre le Cancer Oscar Lambret [Lille] (UNICANCER/Lille), Université de Lille-UNICANCER, Institut de Cancérologie de l'Ouest [Angers/Nantes] (UNICANCER/ICO), UNICANCER, CIC - HEGP (CIC 1418), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Léon Bérard [Lyon], Hôpital de la Timone [CHU - APHM] (TIMONE), Institut de Cancérologie de Lorraine - Alexis Vautrin [Nancy] (UNICANCER/ICL), Centre Régional de Lutte contre le Cancer François Baclesse [Caen] (UNICANCER/CRLC), Normandie Université (NU)-UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN), Institut de Génétique Moléculaire de Montpellier (IGMM), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Institut de recherche en cancérologie de Montpellier (IRCM - U896 Inserm - UM1), Université Montpellier 1 (UM1)-CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), CRLC Val d'Aurelle-Paul Lamarque, Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), Université Lille Nord de France (COMUE)-UNICANCER, UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN)-Normandie Université (NU), Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM), CRLCC Val d'Aurelle - Paul Lamarque-Université de Montpellier (UM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Montpellier 1 (UM1), Institut de Recherche en Cancérologie de Montpellier (IRCM - U1194 Inserm - UM), CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Centre Antoine Lacassagne, CRLCC Antoine Lacassagne, CRLCC Oscar Lambret, Institut de Cancérologie de l'Ouest, Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpital Européen Georges Pompidou [APHP] (HEGP), Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut de Cancérologie de Lorraine - Alexis Vautrin (ICL), Centre Régional de Lutte contre le Cancer François Baclesse (CRLC François Baclesse ), Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN), Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)

المصدر: British Journal of Cancer
Breast Cancer Research and Treatment
Breast Cancer Research and Treatment, 2014, 110, pp.1148--54. ⟨10.1038/bjc.2013.813⟩
Breast Cancer Research and Treatment, Springer Verlag, 2014, 110, pp.1148--54. ⟨10.1038/bjc.2013.813⟩

مصطلحات موضوعية: Male, Cancer Research, Colorectal cancer, medicine.medical_treatment, Camptothecin/administration & dosage/analogs & derivatives, Gastroenterology, tyrosine kinase inhibitor, Antineoplastic Combined Chemotherapy Protocols, Clinical endpoint, 80 and over, clinic, Aged, 80 and over, education.field_of_study, metastatic colorectal cancer, ras Proteins/*genetics, Mutation, Middle Aged, Sorafenib, 3. Good health, Oncology, Disease Progression, Female, Colorectal Neoplasms, medicine.drug, Adult, Niacinamide, medicine.medical_specialty, Niacinamide/administration & dosage/analogs & derivatives, Population, Colorectal Neoplasms/*drug therapy/genetics, [SDV.CAN]Life Sciences [q-bio]/Cancer, Neutropenia, Irinotecan, Disease-Free Survival, Proto-Oncogene Proteins p21(ras), Internal medicine, Proto-Oncogene Proteins, medicine, Humans, Antineoplastic Combined Chemotherapy Protocols/*therapeutic use, education, neoplasms, Aged, Chemotherapy, business.industry, Phenylurea Compounds, medicine.disease, digestive system diseases, Surgery, KRAS gene mutation, Regimen, Phenylurea Compounds/administration & dosage, Clinical Study, ras Proteins, Proto-Oncogene Proteins/*genetics, Camptothecin, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0de27d5b42bd45149c4970a8cb5a2512Test
http://europepmc.org/articles/PMC3950852Test

المؤلفون: Lieveke Ameye, Raphaël Maréchal, Amélie Deleporte, Irina Vierasu, Erwin Woff, Thomas Guiot, Camilo Garcia, Alain Hendlisz, Thierry Delaunoit, Gauthier Demolin, Namur Gauthier, Renaud Lhommel, Patrick Flamen, Marc Van den Eynde, Stéphane Holbrechts

المساهمون: UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie, UCL - (SLuc) Service de médecine nucléaire, UCL - (SLuc) Unité d'oncologie médicale, UCL - (SLuc) Centre du cancer

المصدر: European Journal of Nuclear Medicine and Molecular Imaging
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 43, p. 1792-1801 (2016)
European journal of nuclear medicine and molecular imaging, 43 (10

مصطلحات موضوعية: Oncology, Male, Colorectal cancer, medicine.medical_treatment, Phenylurea Compounds -- administration & dosage, 030218 nuclear medicine & medical imaging, Targeted therapy, Tumoral heterogeneity, 0302 clinical medicine, Positron Emission Tomography Computed Tomography, Antineoplastic Combined Chemotherapy Protocols, Radiopharmaceuticals -- pharmacokinetics, Molecular Targeted Therapy, Fluorodeoxyglucose F18 -- pharmacokinetics, Imagerie médicale, radiologie, tomographie, Metastatic colorectal cancer, Colorectal Neoplasms -- diagnostic imaging -- drug therapy -- secondary, General Medicine, Middle Aged, Sorafenib, Treatment Outcome, Drug Monitoring -- methods, Radiology Nuclear Medicine and imaging, 030220 oncology & carcinogenesis, Fdg pet ct, Female, Original Article, Niacinamide -- administration & dosage -- analogs & derivatives, medicine.symptom, Drug Monitoring, Colorectal Neoplasms, medicine.drug, Adult, Niacinamide, medicine.medical_specialty, Sensitivity and Specificity, Capecitabine, Lesion, FDG PET-CT, 03 medical and health sciences, Fluorodeoxyglucose F18, Internal medicine, medicine, Volume reduction, Humans, Molecular Targeted Therapy -- methods, Radiology, Nuclear Medicine and imaging, Aged, business.industry, Phenylurea Compounds, Reproducibility of Results, Positron Emission Tomography Computed Tomography -- methods, medicine.disease, Capecitabine -- administration & dosage, Discontinuation, Antineoplastic Combined Chemotherapy Protocols -- administration & dosage, Radiopharmaceuticals, business, Early metabolic response assessment

وصف الملف: 1 full-text file(s): application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e0aa1f3a5363635b991f75146123099Test
https://pubmed.ncbi.nlm.nih.gov/27072811Test

المؤلفون: Samalin, E., Bouche, O., Thezenas, S., Francois, E., Adenis, Antoine, Bennouna, J., Taieb, J., Desseigne, Françoise, Seitz, J. F., Conroy, T., Galais, M. P., Assenat, Eric, Crapez, Evelyne, Poujol, Sylvain, Bibeau, Frédéric, Boissiere, F., Laurent-Puig, P., Ychou, Marc, Mazard, Thibault

المساهمون: CRLCC Val d'Aurelle - Paul Lamarque, Hôpital universitaire Robert Debré Reims (CHU Reims), Centre de Lutte contre le Cancer Antoine Lacassagne Nice (UNICANCER/CAL), UNICANCER-Université Côte d'Azur (UniCA), Centre Régional de Lutte contre le Cancer Oscar Lambret Lille (UNICANCER/Lille), Université de Lille-UNICANCER, Institut de Cancérologie de l'Ouest Angers/Nantes (UNICANCER/ICO), UNICANCER, CIC - HEGP (CIC 1418), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Européen Georges Pompidou APHP (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Léon Bérard Lyon, Hôpital de la Timone CHU - APHM (TIMONE), Institut de Cancérologie de Lorraine - Alexis Vautrin Nancy (UNICANCER/ICL), Centre Régional de Lutte contre le Cancer François Baclesse Caen (UNICANCER/CRLC), Normandie Université (NU)-UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN), Institut de Génétique Moléculaire de Montpellier (IGMM), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Institut de recherche en cancérologie de Montpellier (IRCM - U896 Inserm - UM1), Université Montpellier 1 (UM1)-CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), CRLC Val d'Aurelle-Paul Lamarque, Hôpital Européen Georges Pompidou APHP (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)

المصدر: ISSN: 0167-6806.

مصطلحات موضوعية: Humans, Female, Middle Aged, Adult, Male, Aged, 80 and over, Proto-Oncogene Proteins/*genetics, ras Proteins/*genetics, Disease-Free Survival, clinic, Disease Progression, Antineoplastic Combined Chemotherapy Protocols/*therapeutic use, Mutation, Camptothecin/administration & dosage/analogs & derivatives, Colorectal Neoplasms/*drug therapy/genetics, Niacinamide/administration & dosage/analogs & derivatives, Phenylurea Compounds/administration & dosage, [SDV.CAN]Life Sciences [q-bio]/Cancer

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/24407191; hal-02181353; https://hal.umontpellier.fr/hal-02181353Test; PUBMED: 24407191; PUBMEDCENTRAL: PMC3950852

الإتاحة: https://doi.org/10.1038/bjc.2013.813Test
https://hal.umontpellier.fr/hal-02181353Test

المؤلفون: Thomas Hundsberger, Dietrich Py, N. Dunkel, A. Ben Aissa, Maria Vargas, Andreas F. Hottinger, Karl Lothard Schaller, Vittoria Espeli, Nicolas Mach, D. Squiban, Damien C. Weber, A Bodmer

المصدر: British Journal of Cancer, vol. 110, no. 11, pp. 2655-2661
British Journal of Cancer
British Journal of Cancer, Vol. 110, No 11 (2014) pp. 2655-2661

مصطلحات موضوعية: Oncology, Male, Cancer Research, medicine.medical_treatment, Pharmacology, urologic and male genital diseases, radiation therapy, tyrosine kinase inhibitor, Antineoplastic Combined Chemotherapy Protocols, heterocyclic compounds, ddc:616, Glioblastoma/mortality/therapy, Brain Neoplasms, Chemoradiotherapy, Middle Aged, Sorafenib, Brain Neoplasms/mortality/therapy, female genital diseases and pregnancy complications, Phase i study, Dacarbazine, Treatment Outcome, Female, Corrigendum, high-grade glioma, medicine.drug, Adult, Niacinamide, medicine.medical_specialty, Niacinamide/administration & dosage/analogs & derivatives, Maximum Tolerated Dose, ddc:616.0757, pharmacokinetic study, Disease-Free Survival, Glioma, Internal medicine, medicine, Temozolomide, Humans, neoplasms, Aged, business.industry, Phenylurea Compounds, medicine.disease, digestive system diseases, ddc:616.8, First line treatment, Radiation therapy, Phenylurea Compounds/administration & dosage, Clinical Study, Antineoplastic Combined Chemotherapy Protocols/pharmacokinetics/therapeutic use/toxicity, Dacarbazine/administration & dosage/analogs & derivatives, business, Glioblastoma

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5769967950cf20f0072e4f151af7bd83Test
https://serval.unil.ch/resource/serval:BIB_A3EE92645B9C.P001/REF.pdfTest

المؤلفون: Pascal Wolter, Alexandra Karadimou, Jean-Jacques Body, Patrick Schöffski, H. Van Poppel, Ludo Willems, Benoit Beuselinck, Philip R. Debruyne, Annick Rogiers, T. van Cann, R. Elaidi, Robert Paridaens, Herlinde Dumez, Joost Berkers, Evelyne Lerut

المصدر: British Journal of Cancer
British Journal of Cancer, 107 (10

مصطلحات موضوعية: Male, Cancer Research, Pathology, Diphosphonates -- administration & dosage -- adverse effects, Indoles, Phenylurea Compounds -- administration & dosage, Antineoplastic Combined Chemotherapy Protocols -- adverse effects -- therapeutic use, Targeted therapy, bone metastases, Renal cell carcinoma, Antineoplastic Combined Chemotherapy Protocols, Bone Density Conservation Agents -- administration & dosage -- adverse effects, Bone Neoplasms -- drug therapy -- pathology -- secondary, Sunitinib, Neoplasm Metastasis, Indoles -- administration & dosage, Outcome, Bone Density Conservation Agents, Diphosphonates, Protein Kinase Inhibitors -- administration & dosage, Osteonecrosis, Bisphosphonates, Sciences bio-médicales et agricoles, Middle Aged, Protein-Tyrosine Kinases, Sorafenib, Prognosis, targeted therapy, Kidney Neoplasms, Treatment Outcome, Oncology, outcome, Female, Niacinamide -- administration & dosage -- analogs & derivatives, Tyrosine kinase, medicine.drug, Carcinoma, Renal Cell -- drug therapy -- pathology -- secondary, Niacinamide, medicine.medical_specialty, renal cell carcinoma, Bone Neoplasms, Osteonecrosis -- chemically induced, Disease-Free Survival, Kidney Neoplasms -- drug therapy -- pathology, Pyrroles -- administration & dosage, medicine, Carcinoma, Humans, Pyrroles, Carcinoma, Renal Cell, Protein Kinase Inhibitors, bisphosphonates, Retrospective Studies, Osteonecrosis of the jaw, business.industry, Protein-Tyrosine Kinases -- antagonists & inhibitors, Bone metastases, Phenylurea Compounds, medicine.disease, osteonecrosis of the jaw, Concomitant, Cancer research, Clinical Study, business

وصف الملف: 1 full-text file(s): application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdb22c4137af4f142fa2a48d0882b042Test
https://pubmed.ncbi.nlm.nih.gov/23132391Test

المؤلفون: Suryapranata, H. (Harry), Serruys, P.W.J.C. (Patrick), Feyter, P.J. (Pim) de, Verdouw, P.D. (Pieter), Hugenholtz, P.G. (Paul)

المصدر: The American Journal of Cardiology vol. 61, pp. 292-297

مصطلحات موضوعية: 0 (Vasodilator Agents), 65141-46-0 (Nicorandil), 98-92-0 (Niacinamide), Adult, Aged, Blood Pressure/drug effects, Coronary Angiography, Coronary Circulation/drug effects, Coronary Disease/physiopathology, Coronary Vessels/*drug effects/physiopathology, Female, Human, Male, Middle Aged, Myocardium/metabolism, Niacinamide/administration & dosage/*analogs & derivatives/pharmacology, Nicorandil, Oxygen Consumption/drug effects, Vascular Resistance/drug effects, Vasodilation/*drug effects, Vasodilator Agents/*administration & dosage/pharmacology

وصف الملف: application/pdf

العلاقة: http://repub.eur.nl/pub/4277Test; urn:hdl:1765/4277

الإتاحة: http://repub.eur.nl/pub/4277Test

المصدر: European journal of nuclear medicine and molecular imaging, 43 (10

مصطلحات الفهرس: Imagerie médicale, radiologie, tomographie, Adult, Aged, Antineoplastic Combined Chemotherapy Protocols -- administration & dosage, Capecitabine -- administration & dosage, Colorectal Neoplasms -- diagnostic imaging -- drug therapy -- secondary, Drug Monitoring -- methods, Female, Fluorodeoxyglucose F18 -- pharmacokinetics, Humans, Male, Middle Aged, Molecular Targeted Therapy -- methods, Niacinamide -- administration & dosage -- analogs & derivatives, Phenylurea Compounds -- administration & dosage, Positron Emission Tomography Computed Tomography -- methods, Radiopharmaceuticals -- pharmacokinetics, Reproducibility of Results, Sensitivity and Specificity, Sorafenib, Treatment Outcome, Early metabolic response assessment, FDG PET-CT, Metastatic colorectal cancer, Targeted therapy, Tumoral heterogeneity, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article

URL: https://dipot.ulb.ac.be/dspace/bitstream/2013/282990/3/doi_266617.pdfTest
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/282990Test
http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLLTest